Business
Bionano Genomics Announces Presentation of OGM Utility Across Key Applications at American Society of Human Genetics (ASHG) Annual Meeting
Dr. Alka Chaubey, chief medical officer at Bionano, and Dr. Nikhil Sahajpal, fellow at Greenwood Genetic Center, will host a sponsored vendor presentation on
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"Dr. Alka Chaubey, chief medical officer at Bionano, and Dr. Nikhil Sahajpal, fellow at Greenwood Genetic Center, will host a sponsored vendor presentation on a large clinical study utilizing optical genome mapping (OGM) for analysis of postnatal genetic disorders and the complementary use of OGM and next generation sequencing (NGS) to solve undiagnosed casesA scientific presentation featuring Dr. Tuomo Mantere, University of Oulu, Dr. Laila El-Khattabi, Hôpitaux de Paris – Université de Paris, Dr. Rashmi Kanagal-Shamanna, MD Anderson Cancer Center, and Dr. Adam Smith, University Health Network will cover the use of OGM in molecular cytogenetic research, as well as the utilization and limitations of short- and long-read sequencing to detect SVsTwenty-two scientific poster presentations will illustrate the application of Bionano’s OGM technology in research areas including schizophrenia, ataxia and neurodevelopmental disorders Bionano and Hamilton will share updated data from studies utilizing their collaborative solution, the Long String VANTAGE, which is the world’s first automation solution for ultra high molecular weight (UHMW) DNA extraction used in OGM Before the conference, Bionano will host customers, key opinion leaders (KOLs), and VIPs from the genomics and cytogenetics communities for education and networking at a “Meet the User” event at the Bionano Laboratories facility SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in American Society of Human Genetics (ASHG) Annual Meeting 2022. For the first time, ASHG will feature a dedicated scientific session on genome mapping technologies, with researchers highlighting optical genome mapping (OGM) as a technique that has the potential to revolutionize molecular and cytogenetic research. A record twenty-four scientific and poster presentations will cover OGM’s utility in genetic disease research and other research areas including schizophrenia, ataxia, constitutional and neurodevelopmental disorders. ASHG’s Annual Meeting brings together industry, medical, and academic professionals to discuss advances in clinical genomics and genetics research. ASHG conference sessions will take place October 25-29, 2022 in Los Angeles, California. As part of a hosted CoLab session, Bionano’s chief medical officer, Alka Chaub...